Stocks
Cogent Biosciences, Inc.COGT
NASDAQHealthcareBiotechnology$34.00-3.76%
A clinical-stage biotechnology company focused on developing precision therapies targeting genetically defined diseases, particularly disorders driven by mutations in the KIT receptor tyrosine kinase. Its lead programs include small‑molecule inhibitors designed to treat systemic mastocytosis and oth...
Market Cap: $5.5B52W Range: $3.72 – $43.73
Congressional Interest in Cogent Biosciences, Inc. (COGT)
1 member of Congress has disclosed 1 trade in Cogent Biosciences, Inc. (COGT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading COGT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | buy | $1K – $15K |